![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 16, 2019 9:53:46 AM
Could be days or weeks yet; but ya better be positioned. Once finalized, I expect new management to take over and investors to rapidly bid this up..
Keep in mind..
With minimal debt; this stock is trading around 1 million valuation
Diabetes Relief is growing exponentially, expecting roughly 2.5 million in revs this fiscal year and with opening new facilities and leveraging public markets; one could easily project 4-5 mil revs for a forward 12 months.
On top of that... the Diabetes Relief facilities open up a cost efficiency and monetization path for Liprostin.. that is a huge bonus to get JV financiers or partners on board for phase 3 clinicals. This did not exist prior to DR combination.
With DR business model and the potential for phase 3 clinicals unlocked; I see an initial valuation of 10-20 mil short term. Longer term if DR growth rate continued and phase 3 clinicals mature down a path; 50-100 mil is very possible 12 month target.. sometimes the frenzy comes in way early. So really anything is possible in OTC world and this has such a tight share structure. Biotech’s sometimes run to 100 mil valuations prematurely too..
Current prices are laughable; so I accumulate weekly.
Recent GSTC News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/17/2024 08:05:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 04:33:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/19/2024 10:13:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 09:21:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 05:32:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/17/2023 08:01:04 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:31:39 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM